Guizhou Yibai Pharmaceutical Co.,Ltd. Posted 438.3 Million Yuan Net Loss in 2022

Guizhou Yibai Pharmaceutical Co.,Ltd. (贵州益佰制药股份有限公司) (600594.SH) reported a net loss of 438.3 million yuan in 2022, reversing a net profit of 230.8 million yuan for the previous year.

Meanwhile, the company posted 2.7 billion yuan in revenue, down 18.3% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 34.4%.